BioRestorative Therapies (BRTX) 10-K2022 FY Annual report

Filed: 24 Mar 23, 6:55pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: Bethesda, Biden, cap, Child, clarify, Depository, Dx, Eunice, FINITE, Finland, Fleetco, flow, gap, inflation, IRA, Kennedy, lumber, Maryland, merger, month, Neuro, ovary, polycystic, rebate, recommenced, SBIR, shelf, Sheng, Shriver, Simultaneously, subdivision, syndrome, Temple, Triangle, unissued, upcoming, Wu

Removed: assistance, attached, bankruptcy, bifurcated, bore, call, chapter, closely, commitment, Confirmation, confirming, consisted, consultation, convene, Coventry, creditor, daily, default, DIP, divided, dollar, Eastern, ECO, effectuate, enjoining, entertainment, estimable, extinguished, feature, fixed, fulfilled, fulfilling, furnish, Gerard, hearing, hope, hybrid, inclusive, input, Intercreditor, intrinsic, Jersey, John, Lattice, lender, lessen, Malanga, mandatory, mitigate, Multinomial, ordered, petition, plaintiff, ratio, recomputed, recurring, reorganization, repeal, reserving, restraining, restriction, segregation, selling, separated, split, standing, sum, Task, thinly, tradeable, transferrable, transform, trust, trustee, twenty, uneffected, unsecured, viii

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BRTX similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. § 1350, the undersigned officers of BioRestorative Therapies, Inc. (the “Company”) hereby certify that the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

		/s/ Lance Alstodt
Date: March 24, 2023		Lance Alstodt
		Principal Executive Officer

		/s/ Robert Kristal
		Robert Kristal
		Principal Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

Exhibit 32

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

		/s/ Lance Alstodt
Date: March 24, 2023		Lance Alstodt
		Principal Executive Officer

		/s/ Robert Kristal
		Robert Kristal
		Principal Financial Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.